1GANZ PA.Quality of life and the patient with cancer: individial and policy implications[J].Cancer (Supple),1994,74(4):1445-1452. 被引量：1
2STEWART AL,HAYS RD,WARE JE.The MOS short-form general health survey: reliablity and validity in a patient population[J].Med Care,1988,26:724-735. 被引量：1
3JACOBSON AM,SAMSON JA,GROUT MD,et al.The evaluation of two measures of quality of life in patients with type 1 and type 2 diabetes[J].Diabetes Care,1994,17:267-274. 被引量：1
4WARE JE,SHEBOURNE CD.The MOS 36-item short from health survey (SF 36): 1.conceptual fromework and item selection[J].Med Care,1992,30:473-483. 被引量：1
6STREINER DL,NORMAN GR.Health measurement scales: a practical guide to their develepment and use[M].Oxford.New York.Tokyo:Oxford University Press,1994:31-45. 被引量：1
7GUYATT GT.Measuring disease specific quality of life in clinical trails[J].Can Med Assoc J,1986,134:889. 被引量：1
9JOHNSON JA,NOWATZKI TE,COONS SJ.Health related quality of life of diabetes pima indians[J].MED Care,1996,34:97-102. 被引量：1
100HIRSCH A,BARTHOLOMAE C,VOLMER T.Dimensions of quality of life in people with non insulin dependent diabetes[J].Quality of Life Reaserch,2000,9:207-218. 被引量：1
二级参考文献9
1World Health Organization.Diabetes mellius:report of a study group[C]. Geneva:WHO Tech Rep Ser.1985.25～ 26 被引量：1
2Johnson JA,Nowatzki TZ,Pharmd,et al.Health related quality of life of diabetic Pima indians[J].Med Care,1996,34:97～ 102 被引量：1
3Waltz CF.Measurement in nursing research[M].Philadelphia:FA.Davis Company.1991.48～ 50 被引量：1
5Streiner DL,Norman GR.Health measurement scales:a practical guide to their develepment and use[M].Oxford,New York.Tokyo.Oxford university press.1994.136～ 138 被引量：1
6Stewart AL,Hays RD,Ware JE.The MOS short form general health sur-vey： reliablity and validity in a patient population[J].Med Care,1988, 26:724～ 735 被引量：1
7Jacobson AM,Samson JA,Grout MD,et al.The evaluation of two mea-sures of quality of life in patients with type 1 and type 2 diabetes[J].Dia-betes Care,1994,17:267～ 274 被引量：1
8Johnson JR,Temple R.Food and drug administration requirements for approval of new anticancer drugs[J].Cancer Treat Rep,1985,69:1 155～1 158 被引量：1
